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Finding the global in the local: 




Since the birth of genetics in the early twentieth century geneticists 
have been keen to understand what their science can say about how 
humans differ from one another, including how they differ from one 
part of the globe to another. Since the early 1990s there has been a 
notable surge in initiatives aiming to describe and analyse the genetic 
make-up of people living outside Europe and North America. Some of 
these initiatives profess a primarily anthropological orientation, aiming 
to capture and document as much as possible of the sheer diversity of 
human genetic constitutions: the Human Genome Diversity Project 
and National Geographic’s Genographic Project are cases in point. 
Other initiatives – often framed in terms of documenting genetic 
‘variation’ rather than ‘diversity’ – claim a more practical orientation 
towards identifying gene variants of medical significance: the Interna-
tional Haplotype Mapping (HapMap) Project and the African Genome 
Variation Project exemplify this latter approach to human genetics. In 
explaining the medical value of such work, advocates commonly state 
that it will generate genetic information that will help to combat illness 
and foster health in the countries under study. Thus the International 
HapMap Project is framed in terms of the ‘need to be inclusive in 
the populations that we study to maximize the chance that all people 
will eventually benefit from this international research effort’ (NIH 
News Advisory, 2002); while the African Genome Variation Project is 
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presented as a step towards ‘provid[ing] a comprehensive resource for 
medical genomic studies in Africa’ (Gurdasani et al., 2015: 331).
In this chapter I look beyond such professions of intent to examine 
a broader set of drivers that have structured the global expansion of 
genomic research and that skew how its findings are used. I show how 
recent initiatives to document the genetic constitution of people living 
in the world’s poorer regions have actually grown out of, and serve the 
purposes of, efforts to identify genetic factors which influence the 
health of people living predominantly in the global North. This is 
perhaps unsurprising. For one thing, most research into the genetics of 
disease and ill health has been conducted by researchers based in the 
wealthiest countries of Europe and North America. For another, such 
research is to a significant extent driven by commercial interests, in the 
hope of profiting financially from any resulting medical innovations; 
consequently, research has tended to focus on understanding the ail-
ments affecting those sections of the world’s population that are most 
likely to be able to afford such innovations. In which case, why the 
recent turn to study the genomes of people living outside these rich 
regions? This chapter sets out to answer this question through a histori-
cal study of the changing aims and methodologies of medical genetics 
and human population genetics, and their recent convergence around 
new approaches to identifying genetic causes of ill health and disease.
Based on a close reading of medical genetics research literature, I 
show how, between the 1980s and the early 2000s, the focus of that 
research shifted from rare single-gene disorders to the genetics of 
common complex disorders such as heart disease and diabetes. I show 
how that shift in focus involved a shift in methodology: from studying 
the hereditary transmission of disease within families, to searching for 
correlations between genes and disease in populations. In particular, I 
show how a new approach to characterizing and analysing genetic pop-
ulations came to be articulated in the course of this methodological 
turn. This new approach arose from the hybridization of two different 
and longer-established ways of thinking about populations. On the one 
hand, it drew on mainstream epidemiological ideas of populations as 
artificial constructs, created and defined for the purposes of research 
itself. And on the other hand, it drew on ideas inherited from older 
approaches to human population genetics which supposed that distinct 
genetic populations, far from being constructed by researchers, actually 
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exist in nature and are simply characterized and differentiated through 
the use of appropriate research methods. I argue that the adoption of 
this novel approach to populations as a basis for identifying genetic 
causes of common disorders was one of the principal drivers, in the 
1990s, for the surge of interest in the genetics of people living outside 
the global North. Specifically, as we shall see, knowledge of particular 
genotypes that occur with different frequency in different parts of the 
world was deemed necessary so as to control for the confounding 
effects of so-called ‘population structure’ in the search for correlations 
between diseases and genes. In practice, this knowledge has over-
whelmingly been used to facilitate research into disease–gene correla-
tions among white Europeans and North Americans. As a result, the 
net effect of the globalization of genetic research has not been to reduce 
global inequalities in research into disease, its causes and treatment, 
but, if anything, to exacerbate them.
Populations and disease genes in the 1950s to 1970s
During the immediate post-war years research into human population 
genetics and research into genetic factors in human disease tended to 
diverge in their aims and methods. Consider first the research aimed at 
identifying genetic causes of disease. Such work focused primarily on 
single-gene disorders. These are mostly rare conditions, such as Hun-
tington’s disease or phenylketonuria, in which individuals possessing 
either one or more usually two variant copies (depending on the condi-
tion) of a particular gene will usually develop, sooner or later, the phe-
notypic signs of that condition. In such disorders researchers can trace 
transmission of the relevant genetic variants through successive genera-
tions of a family using the theoretical schema of Mendelian genetics. 
Family pedigrees accordingly served as the principal objects of research 
for medical geneticists interested in identifying and tracking such dis-
orders, and remained so during the 1960s and 1970s, with researchers 
often devoting considerable effort to seeking out and cultivating affected 
families (see, inter alia, Comfort, 2012: 97–129; Gaudillière, 2000; 
Lindee, 2005; Nukaga, 2002).
As well as following the inheritance of genetic disorders from one 
generation to the next, medical geneticists were also keen to map the 
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location of the causal gene variants onto the human chromosomes. 
Gene-mapping techniques had been developed from the 1920s by 
geneticists working in the laboratory with experimental animals and 
plants. These techniques involved observing a phenomenon known 
as linkage. According to classical Mendelian genetics, in the course 
of sexual reproduction the alleles of any one gene will normally be 
distributed among members of the next generation quite indepen-
dently of the alleles of any other gene. However, if two genes happen 
to be situated close together on the same chromosome their alleles 
will tend to be inherited together in a non-random fashion; in such 
cases, the genes are said to display linkage. The greater the ten-
dency for alleles to be inherited together, the closer the linkage, and 
the closer together the relevant genes are assumed to be situated on 
the chromosome. By conducting controlled mutation and breeding 
experiments and observing multiple Mendelian traits, by the early 
post-war years geneticists had been able to construct genetic linkage 
maps of a range of organisms from the fruit fly Drosophila to maize 
and laboratory mice (Kohler, 1994; Rheinberger and Gaudillière,  
2004).
Linkage mapping in experimental organisms played an important 
role in the development of genetics as a scientific discipline during the 
first half of the twentieth century. For medical geneticists it also offered 
a possible route to more practical benefits. If a genetic disorder could 
be shown to be linked to a more easily observable trait, the presence of 
that trait might serve as a diagnostic marker, enabling clinical geneti-
cists to identify the disease before the onset of symptoms or to identify 
carriers who would not themselves develop the disease but could pass 
on the offending genetic variant to their offspring. Humans did not lend 
themselves well to available methods of genetic linkage mapping, 
however. For one thing, humans are not generally regarded as appropri-
ate subjects for systematic breeding experiments. For another, humans 
are a young species in evolutionary terms and so are less genetically 
diverse than many other organisms. Consequently, they exhibit rela-
tively few of the kinds of Mendelian traits that can be followed from 
one generation to the next. Given the paucity of such traits, such genetic 
linkage maps as were constructed up to the late 1970s contained rela-
tively few genes, including no more than a handful of genetic disorders, 
158 Global health and the new world order
while the degrees of linkage remained too tenuous to be of diagnostic 
or predictive value (Harper, 2008: 194–212).
While medical geneticists concentrated on families in their search 
for disease genes, human population geneticists pursued a rather differ-
ent set of concerns during the post-war decades. Their principal aim 
was to elucidate the history and dynamics of human evolution – an 
enterprise which they conducted in sometimes fractious dialogue with 
physical anthropologists (Smocovitis, 2012). Beginning in the nine-
teenth century, studies of human evolution initially focused on efforts 
to characterize distinct races of humanity and to chart the hierarchical 
relationships between them. The anthropological and anthropometric 
techniques employed for this purpose were augmented during the first 
half of the twentieth century by new genetic methods of defining and 
differentiating populations, in particular by observing differences in the 
frequency of certain common genotypes. In particular, the realization 
that the ABO system of blood groups followed a simple pattern of 
genetic determination paved the way to large-scale population surveys 
of the distribution of different genotypes, made possible by the ease of 
collecting, storing, transporting and serotyping blood samples (Gannet 
and Griesemer, 2004; Marks, 2012). The post-war years saw further 
expansion in both the scale and geographical scope of such surveys, as 
well as the identification of additional serological markers of genetic 
difference (Bangham, 2014; Radin, 2014).
At the same time, dominant views about the nature of human evo-
lutionary relationships were shifting as anthropologists and geneticists 
alike sought to cast off earlier, overtly racist assumptions about human 
difference. By the 1960s concerns to identify distinct racial types had 
largely given way to a more dynamic and relativistic understanding 
of human population. Earlier race theorists had posited that races 
constituted discrete geographically or reproductively separate popula-
tions. By contrast, post-war population geneticists were increasingly 
inclined to envisage a single, continuous global population connected 
by constant migration and interbreeding and structured not by discrete 
boundaries but by continuous variation in gene frequency from one 
part of the world to another. Consequently, they argued, biology could 
provide no basis for essentialist ideas of race. However, disagreements 
remained over whether this shift in thinking meant that it no longer 
made sense to talk about biological races at all. Some post-war human 
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geneticists argued that it was still possible to discern distinct human 
populations separated by cultural as well as geographical barriers. Even 
if the boundaries between those populations were blurred and porous, 
they still placed enough restrictions in the way of genetic exchange, 
and the populations they demarcated were still sufficiently different in 
their genetic make-up, to constitute distinct biological races. Others 
adopted a more pragmatic viewpoint. Discrete populations might not 
exist in reality, they argued. But for purposes of genetic research into 
human difference it was useful to behave as if they did, using geographi-
cal or other criteria to demarcate populations to sample and study. As a 
number of historians have observed, such research commonly drew on 
ethnic and other markers of population difference. In so doing it tended 
to reintroduce, albeit implicitly, older assumptions about race into the 
identification of populations for purposes of human genetic research. 
At the same time, that research itself tended to naturalize and reify 
those assumptions by showing that, in many cases, genetic differences 
could indeed be found between the populations so defined. While 
the precise relationship of these genetic differences to other forms 
of racial, ethnic or geographical difference continued to be debated, 
the circular reasoning underlying much of that research went largely 
unremarked, thereby helping to sediment assumptions that racial and 
ethnic differences are at least partly rooted in biology (see, inter alia, 
Bangham, 2015; Gannet, 2001, 2003; Gannet and Griesemer 2004; 
Gormley, 2009; Lipphardt, 2014; Marks, 2012; Reardon, 2004, 2005; 
Smocovitis, 2012).
On the whole, this line of research into population genetics offered 
little of practical interest to medical geneticists, at least at that time. 
Medical geneticists did sometimes take an ambivalent interest in the 
kinds of large-scale population surveys of variation in gene frequency 
that flourished in the post-war decades (de Chadarevian, 2014) – chiefly 
in the hope that they would provide insight into hereditary influences 
on susceptibility to infectious diseases and common disorders such 
as heart disease, as well as rare single-gene disorders. However, while 
such research certainly provided new epidemiological information 
about variability in disease incidence, it was less informative about sup-
posed genetic determinants of that variation. Even where such research 
helped to throw new epidemiological light on the incidence of rare 
genetic disorders those findings were rarely of much practical benefit 
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to medical geneticists. The observation that gene variants associated 
with sickle cell disease appeared to confer a selective advantage on 
people living in malarial regions of the world, for instance, provided 
population geneticists with a neat example of how evolutionary theory 
could be applied to humans. For medical geneticists, meanwhile, the 
same findings helped to direct diagnostic attention in ways that often 
reflected racial assumptions about predisposition to disease (Wailoo 
and Pemberton, 2008). More generally, evidence of population-based 
variation in disease incidence proved largely unpersuasive as an argu-
ment for genetic causation: unless researchers could demonstrate clear 
Mendelian patterns of inheritance, they found it difficult to argue 
that increased incidence was due to genetic rather than environmen-
tal causes, as was evident for instance in the case of familial cancers 
(Cantor, 2006; Necochea, 2007). Consequently, despite the growth in 
research into population genetics during the 1960s and 1970s, medical 
geneticists continued to focus their attention on families rather than 
populations.
However, there was one important exception to this generalization. 
One key site where the interests of population geneticists and medical 
geneticists came into productive dialogue with one another was in 
relation to so-called ‘population isolates’. Population geneticists had 
coined this term to denote specific populations which they considered 
to have been reproductively isolated, be it for geographical or cultural 
reasons, from the larger human gene pool. Groups identified as popula-
tion isolates were typically quite small in size, although they included 
some larger groups such as the Finns and the Basques. They were also 
considered to be atypical in a world elsewhere dominated by movement 
and interbreeding. And that atypicality made them uniquely valuable. 
Human geneticists regarded population isolates as relics from older 
periods of population history, biologically untouched by more recent 
flows of people and genes that had shaped present-day populations. As 
such, they were seen to offer unique insight into human evolution. But 
they were also seen to be at risk. With the growing speed and reach of 
modern population movements, small population isolates were increas-
ingly vulnerable to out-breeding, dilution and, ultimately, dissolution. 
Consequently, population geneticists were anxious to sample and char-
acterize such isolates before they were lost to the homogenizing flood 
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of modernity, and the 1960s and 1970s saw a number of gene-hunting 
expeditions launched, particularly to sample such supposedly ‘primi-
tive’ peoples as the Yanomami whose isolation was assumed to stretch 
back furthest in evolutionary time (Lindee, 2003; Lipphardt, 2012, 
2014).
Medical geneticists, too, were keen to study population isolates – 
although for rather different reasons than population geneticists. For 
medical geneticists, population isolates represented unusually fertile 
ground on which to hunt for rare genetic diseases. Often descended 
from small groups of founders, with high rates of in-breeding and 
consanguinity, population isolates were typically judged to possess 
relatively low genetic diversity. Consequently, while such populations 
would likely harbour fewer genetic disorders, any disorders that did 
occur would do so with far higher frequency than in a larger, more het-
erogeneous population, recurring repeatedly in the pedigrees of densely 
interrelated families. Medical geneticists were therefore keen to work 
with population isolates as a means of identifying disorders which they 
would find much harder spot elsewhere. Unlike population geneticists, 
however, they tended to be less concerned with evolutionary ‘primitive-
ness’ than by accessibility and the availability of well-validated family 
histories. Consequently, medical geneticists were as likely to conduct 
their research among culturally defined ‘isolates’ living in Europe and 
North America, such as Ashkenazi Jews and the Pennsylvania Amish, as 
among more geographically remote populations (Lindee, 2005: 58–89, 
156–186; Wailoo and Pemberton, 2008; Widmer, 2014).
This shared interest in population isolates was one of the few places 
where ideas from population genetics intersected directly with the 
medical geneticists’ efforts to identify disease genes. Overall, work in 
human population genetics and research into genetic causes of human 
disease were notable as much for the extent to which they tended to 
diverge, both theoretically and methodologically, as for their occasional 
overlaps. Where population geneticists focused on statistical observa-
tions of the frequency of common variants within freely interbreeding 
populations, medical geneticists were concerned primarily with tracing 
individual occurrences of rare genetic variants within families. This 
divergence would become more marked during the 1980s as medical 
geneticists adopted new techniques from molecular genetics that 
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enabled them to focus ever more clearly on families rather than other 
kinds of human grouping.
Family studies and molecular mapping
As we have seen, the possibility of conducting genetic linkage studies 
in humans was severely constrained, up to the 1970s, by the paucity of 
common, phenotypically observable genetic variants. However, the 
development of new molecular biotechnologies during the 1970s made 
it possible to circumvent some of those constraints by identifying a 
growing number of variants which do not usually give rise to observable 
phenotypic differences but which can be identified in the laboratory 
using molecular biological techniques. These included so-called restric-
tion fragment length polymorphisms (RFLPs) – specific combinations 
of nucleic acids that can occur at various points in the genome, which 
began to be identified in humans in significant numbers from the late 
1970s; and later, from the early 1990s, microsatellite variants – repeti-
tive sequences of nucleotides scattered through the genome, which vary 
in the number of repeats. Both RFLPs and microsatellite variants 
proved to be much commoner in humans than the kinds of phenotypi-
cally expressed gene variants that had previously been used for linkage 
studies. As such, they provided medical geneticists with a new and 
powerful set of techniques for studying linkage in humans, and ulti-
mately for mapping conditions such as rare genetic disorders that could 
be shown to be linked to these genomic markers.
Medical geneticists first adopted the idea of using RFLP markers to 
study linkage to human disease genes in the late 1970s (Kan and Dozy, 
1978; Solomon and Bodmer, 1979). The first steps in this direction 
were initiated by the Hereditary Disease Foundation (HDF), set up in 
1968 by Dr Milton Wexler following his wife’s diagnosis with Hunting-
ton’s disease, with the aim of promoting research into Huntington’s and 
other genetic conditions. In 1979 the HDF funded a group of geneti-
cists to try to map the Huntington’s disease gene using the new RFLP 
markers. The researcher worked first with an ‘American family of rea-
sonable size’ identified through the National Research Roster for Hun-
tington’s Disease Patients and Families at Indiana University, and 
subsequently with what the researchers described as ‘a unique com-
munity of interrelated Huntingdon’s disease gene carriers living along 
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the shores of Lake Maracaibo, Venezuela’. The researchers struck lucky. 
Employing a panel of only a dozen RFLP markers, in 1983 they were 
able to report the mapping of Huntington’s disease to chromosome 4, 
and the identification of an RFLP marker of potential value in identify-
ing individuals who carried the fatal genetic variant (Gusella et al., 
1983; Nukaga, 2002: 53–57).
Meanwhile, in 1980 a group of American molecular biologists had 
proposed that a concerted programme of identifying RFLPs should be 
undertaken with the aim of constructing a linkage map of the whole 
human genome, in order to facilitate more systematic mapping of genes 
associated with hereditary diseases (Botstein et al., 1980). In 1984, as 
the work on Huntington’s disease made clear the potential of such an 
approach, a group of researchers from the US and France agreed to set 
up an international collaboration, sharing biological materials and ana-
lytical skills with the aim of creating the first complete human linkage 
map. The Centre d’Etude du Polymorphisme Humain (CEPH), as this 
collaboration was called, drew on three sets of three-generation fami-
lies. In France, over 100 families had been recruited during the 1970s to 
provide a tissue-type reference group for the French tissue transplanta-
tion services; ten of these families were subsequently brought into the 
CEPH. In the US, researchers at the Howard Hughes Medical Institute 
in Salt Lake City, including two of the authors of the original 1980 paper 
proposing the construction of an RFLP linkage map, recruited a group 
of Mormon families. Two large families from the ongoing Huntington’s 
disease study in Venezuela were also added to the CEPH’s reference 
panel. Cell lines and pedigree data from these families were distributed 
to an increasingly large network of researchers and the results of linkage 
experiments were shared among the collaborators (Dausset et al., 1990; 
Rabinow, 1999). Using these resources, the first genetic linkage map of 
the whole human genome, involving over 400 genomic markers, was 
published in 1987 (Donis-Keller et al., 1987).
By that time, RFLP linkage data from the CEPH were already being 
successfully used to demonstrate linkage in a variety of hereditary dis-
eases. In 1985 a collaborative study of forty-three Canadian families 
with children affected by cystic fibrosis made use of the accumulating 
body of RFLP markers to report a linked marker on chromosome 7 
(Knowlton et al., 1985; Tsui et al., 1985). Other conditions quickly fol-
lowed, including chronic granulomatous disease, Duchenne muscular 
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dystrophy and a rare genetic cancer called retinoblastoma. Clinical 
geneticists added the linked markers to the range of tools at their dis-
posal for diagnosing and predicting these diseases. Detailed study of 
the inheritance of single-gene disorders through large pedigrees such as 
the Venezuelan Huntington’s disease cohort in turn yielded additional 
markers that could be used to map other genes ( Jones and Tansey, 
2015, 33). By 1986 advocates of RFLP linkage mapping felt sufficiently 
confident to suggest that ‘RFLPs can be found linked to any common 
human disease that shows simple Mendelian transmission and is caused 
by a single genetic locus’ (Lander and Botstein, 1986: 49). Their confi-
dence was further boosted during the early 1990s as researchers added 
microsatellite variants to their panels of RFLP markers, enabling them 
to produce even denser linkage maps of the human genome, while 
also streamlining the process of genotyping samples in the laboratory 
(Kaufmann, 2004; Kruglyak, 2008: 314; Weissenbach et al., 1992). 
By that time, molecular geneticists were not simply mapping the 
markers linked with hereditary diseases but also isolating, cloning and 
sequencing the genes themselves. Building on medical geneticists’ well-
established methods of studying inheritance within families, genomic 
linkage mapping had become a highly productive tool for researchers 
and clinicians working in the genetics of rare diseases.
Towards association studies
At the same time, researchers were becoming increasingly frustrated by 
the limitations of family studies. Such studies were effective for mapping 
the kinds of single-gene disorders which follow Mendelian patterns of 
transmission and segregation from one generation to the next. But 
Mendelian conditions are mostly rare, and attracted little medical inter-
est beyond the specialism of medical genetics. With rapid develop-
ments in molecular biology yielding powerful new research tools, by 
the early 1990s scientists were growing increasingly ambitious to iden-
tify genetic determinants not just of Mendelian disorders but also of 
common disorders such as diabetes and heart disease.
It had long been known that elevated risk of developing some of the 
commonest health disorders often runs in families. Since the late 1950s 
a growing body of research using twin studies and other methods had 
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provided geneticists with what they regarded as compelling evidence 
that a significant proportion of that elevated risk was hereditary rather 
than environmental in origin (Lindee, 2005, ch. 5). However, such 
conditions rarely displayed anything that could be identified as Men-
delian patterns of inheritance; they occurred sporadically, albeit more 
frequently in certain families than in others – a fact that geneticists 
attributed to the involvement of multiple genes, each of which contrib-
uted to the probability of disease occurring but was insufficient on its 
own to make that occurrence a certainty. Researchers agreed that, given 
the sporadic occurrence of such conditions within affected families, 
family linkage methods were largely useless for mapping the predispos-
ing genes (e.g. Lander and Botstein, 1986).
Confronted with these limitations, researchers began to consider 
other methods that they believed would be better suited to identifying 
the genetic factors involved in complex disorders. In place of the kind 
of one-to-one correspondences between genotype and disease that 
were the mainstay of family studies, researchers now looked for ways of 
identifying statistical associations between genomic markers and the 
occurrence of particular diseases, not just within families but among 
larger groups of people. Association studies were well established in 
epidemiology, where they were used to identify associations between 
environmental factors and increased risk of developing certain diseases, 
for instance. However, adapting these methods to study the genetics of 
common disorders was not straightforward. In order to identify a sta-
tistical association between a disease and a particular genetic marker, 
that marker would need to be very tightly linked to the gene that actu-
ally predisposed to that disease. Even with the growing numbers of 
RFLP and microsatellite markers that were available by the early 1990s, 
researchers realized, those markers remained too sparsely scattered on 
the human genome to serve as effective indicators of the presence of 
predisposing genes. If association methods were to have any hope of 
identifying genetic risk factors for complex disorders, it would first be 
necessary to develop human genetic linkage maps to a level of detail 
and resolution that far exceeded what was possible using RFLP and 
microsatellite markers (Bodmer, 1986; Lander and Botstein, 1986).
Consequently, for the time being, researchers sought instead to 
develop hybrid methods that in effect combined elements of family 
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studies with statistical methods for identifying associations. One such 
method, developed in the later 1980s, involved studying large numbers 
of pairs of siblings affected by particular conditions in order to identify 
statistical associations with genetic markers that they possessed in 
common (Bodmer, 1986; Kruglyak and Lander, 1995; Risch, 1989, 
1990a, 1990b). This method proved effective in mapping gene variants 
associated with a number of common diseases, including demonstrat-
ing linkage between type 1 diabetes and a region of chromosome 6 
associated with the body’s immune response (Davies et al., 1994).
Another method, developed around the same time, involved studying 
population isolates where the high degree of in-breeding and interrelat-
edness meant that existing linkage maps were sufficiently fine-grained to 
detect disease associations (Lander and Botstein, 1986: 57–59; Lander 
and Schork, 1994). In the event, this method proved more successful 
in mapping a number of rare single-gene disorders (albeit without the 
need to reconstruct family pedigrees) than the common complex disor-
ders that were increasingly preoccupying medical geneticists (Houwen 
et al., 1994; Puffenberger et al., 1994).
By the mid-1990s further rapid developments in the field of molecu-
lar biotechnology appeared to offer a way to develop more conventional 
forms of association studies. New DNA sequencing technologies con-
nected with the Human Genome Project provided increasingly rapid 
means of identifying much larger numbers of genomic markers than 
had previously been possible. By mapping single nucleotide polymor-
phisms (SNPs) rather than RFLPs and microsatellite variants, much 
higher-resolution linkage maps now became a realistic prospect. This 
promised a step change in the rate at which researchers could identify 
and map human disease genes. Indeed, for a number of the most promi-
nent scientific advocates of the Human Genome Project this was pre-
cisely the purpose of the whole enterprise (Fortun, 1999, 2008: 35–37).
Accordingly, as groups of researchers in Europe and North America 
began systematically collecting, cataloguing and mapping human SNPs 
they came increasingly to regard association methods as the most 
promising means of identifying and mapping gene variants implicated 
in common complex disorders (Collins, Guyer and Chakravarti, 1997; 
Lander, 1996; Risch and Merikangas, 1996). This commitment to cre-
ating the resources necessary to undertake genetic association studies 
would have profound consequences for how molecular and medical 
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geneticists thought about human genetic diversity and, ultimately, 
about human populations.
Capturing human genetic variation
Initially the work of identifying and cataloguing SNPs proceeded in a 
relatively uncoordinated fashion, with the establishment of local data-
bases in a number of leading North American and European research 
centres. However, this work progressed against a backdrop of concern 
that researchers’ access to large bodies of accumulated genomic data 
was threatened by moves to bring those data into private ownership. In 
the summer of 1997 it became apparent that a number of pharmaceuti-
cal companies were seeking to gain proprietary control of some of the 
leading collections of SNPs. In July of that year Abbot Laboratories 
announced a deal with Genset – a private company closely associated 
with the CEPH in Paris – to create two sets of SNPs, one for their own 
private research use and the other to market to other drug companies. 
At the same time Eric Lander, the founding director of the Massachu-
setts Institute of Technology’s Whitehead Institute and one of the 
leading advocates of genetic association studies, was negotiating a deal 
with Bristol-Myers Squibb to create a similarly proprietary collection 
of SNPs to market for use in gene discovery (Marshall, 1997a).
Faced with this threat of privatization, which they feared would 
impede both publicly funded and commercial research into the genet-
ics of disease and ill health, Francis Collins and other leading figures in 
the Human Genome Project were able to negotiate the creation in 1999 
of a public-private partnership called the SNP Consortium, which 
included a number of leading pharmaceutical companies as well as the 
National Human Genome Research Institute (NHGRI) in the US and 
the Wellcome Trust in the UK (NHGRI, 2000). The SNP Consortium 
provided the organization and infrastructure to collate SNP discovery 
projects already under way, including a database called dbSNP which 
would serve as a public repository for the data generated.
More than simply collating existing SNP discovery projects, the 
creation of the SNP Consortium also provided an opportunity to 
impose a degree of order and shared purpose on those projects. In 
particular, it enabled the Consortium leadership to channel research in 
ways that were intended to promote the development of SNP maps that 
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would be optimally configured for use in genetic association studies. 
This led them to seek genomic data of a quite specific kind. SNPs are 
points of genetic variation between individuals. In order to facilitate the 
discovery of SNPs, Consortium members were keen to maximise the 
amount of variation present in the samples they analysed. They were 
helped in that aim by an initiative already under way at the NHGRI. As 
early as 1998 the NHGRI had announced the launch of a new research 
with the specific purpose of facilitating the identification of SNPs. The 
DNA Polymorphism Discovery Resource, as it was called, comprised 
a collection of DNA samples from ‘450 U.S. residents with ancestry 
from all the major regions of the world’ (Collins, Brooks and Chakravarti, 
1998; Marshall, 1997b). With the launch of the SNP consortium in July 
2000, the NHGRI provided twenty-four samples from the DNA Poly-
morphism Discovery Resource, taken from donors ‘with diverse geo-
graphic origins’, to help with its work (NHGRI, 2000). This donation 
proved invaluable in facilitating the search for SNPs. Initially the Con-
sortium had aimed to generate a map of 300,000 evenly spaced SNPs 
within three years. In the event, by the end of 2001 it had succeeded in 
compiling a map detailing over one million SNPs (International SNP 
Map Working Group, 2001).
The NHGRI’s decision to collect and study genetic data from indi-
viduals ‘with diverse geographic origins’ bears careful analysis. The 
architects of the DNA Polymorphism Discovery Resource were at pains 
to declare that it was not intended to support research into the biology 
of racial or ethnic difference; indeed, it was deliberately designed in a 
way that rendered it useless for such research. ‘No medical, phenotypic, 
or ethnicity information is included’ with the samples, they stressed. 
‘The DNA Polymorphism Discovery Resource was designed to be used 
to discover variants in human DNA, not to assess the frequency of vari-
ants in particular groups. Thus, the DNA Polymorphism Discovery 
Resource is not useful for population-specific medical or anthropologi-
cal studies’ (Collins, Brooks and Chakravarti, 1998: 1229–1230).
The reasons for this were partly political. American genome 
researchers were acutely aware that any attempt to undertake genetic 
research that might be seen to impinge on matters of ethnic identity 
would be met with suspicion. A decade earlier, building on post-war 
surveys of human genetic variation as well as the availability of new 
molecular techniques to identify gene variants, population geneticists 
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and physical anthropologists had joined forces to launch the Human 
Genome Diversity Project. The aim was to sample indigenous popula-
tions around the world, particularly what geneticists regarded as endan-
gered population isolates, in order to garner data on human origins and 
evolution (Reardon, 2005). The project had foundered amid charges 
of colonialism and racism. The architects of the DNA Polymorphism 
Discovery Resource therefore sought to distance themselves from that 
earlier debacle. They did so both by removing all racial, ethnic or geo-
graphical identifiers from the samples they collected and by present-
ing their work as an instance of how researchers were responding to 
complaints about Eurocentrism in biomedical research by deliberately 
including other ethnic groups (Bliss, 2012: 49–51).
The removal of ethnic and other identifiers from the DNA Polymor-
phism Discovery Resource was not merely a political gesture, however. 
It was also consistent with the purpose which the Resource was designed 
to serve – namely, to identify SNPs. For that purpose, there was no need 
to know anything about the ethnic or geographical origins of the 
genomes under study; it was sufficient merely to compare them and to 
identify the differences between them. In that respect, the Resource 
marked a significant break with earlier approaches to human genetic 
diversity. Previous anthropologically informed studies of genetic diver-
sity, culminating in the Human Genome Diversity Project, had focused 
on identifying and characterizing the genetic differences between what 
they took to be different populations living or originating in different 
parts of the world – differences that were most starkly exemplified in 
so-called population isolates. In such studies the search for ‘diversity’ 
meant documenting how the human species had become subdivided 
into a number of more or less distinct evolutionary branches or back-
waters. The DNA Polymorphism Discovery Resource certainly drew on 
such assumptions when deciding to recruit individuals whose ancestry 
was seen to lie in different parts of the world. But the aim in doing so 
was markedly different from that of earlier studies. The Resource did 
not seek to identify or describe genetic differences between the ances-
tral populations from which those individuals were supposedly drawn. 
On the contrary, it sought simply to maximise the number and range 
of genetic variants available for mapping. Beyond seeking to recruit as 
diverse a range of individuals as possible, the origins and ancestry of 
the individuals sampled were irrelevant to the aims of these studies 
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– hence the decision to remove geographical identifiers from the col-
lected data. For the purposes of the DNA Polymorphism Discovery 
Resource, the genetic diversity of the population of the US was a useful 
resource, but it was not a matter for analysis.
Reconstituting populations
If the DNA Polymorphism Discovery Resource marked a step away 
from earlier efforts to use genetics to differentiate human populations, 
subsequent research initiatives decisively reasserted the old direction of 
travel. Following the success of the SNP Consortium in cataloguing and 
mapping unexpectedly large numbers of SNPs, scientists at the NHGRI 
proposed an even more ambitious project to identify the kinds of 
genomic variants that would help them to identify genes associated 
with common diseases. In autumn 2002 the US National Institutes of 
Health announced the launch of the International HapMap Project 
(NIH News Advisory, 2002). The aims and methods of the HapMap 
Project differed significantly from those adopted by the DNA Polymor-
phism Discovery Resource.
For one thing, where the SNP Consortium focused solely on sam-
pling American citizens, the HapMap Project looked abroad to sample 
‘several populations from different ancestral geographic locations’: ini-
tially Han Chinese living in Beijing, Japanese living in Tokyo, Yoruba 
from Ibadan in Nigeria and selected members of the Mormon families 
originally collected in 1980 for the CEPH project and classified within 
the HapMap Project as from Northern and Western Europe (Interna-
tional HapMap Consortium, 2003: 791). The reasoning behind this 
decision was again in part political. In the wake of the announcement of 
the first draft of the human genome in February 2001 and the growing 
public prestige that now attached to genome research, many feared that 
confining the research to the US would be seen as exclusionary. At the 
same time, by sampling large, culturally dominant groups in African and 
Asian countries it would be possible to avoid the charges of racism and 
colonialism that had attended the Human Genome Diversity Project. 
While neither of these strategies entirely avoided controversy and 
contestation, they were sufficient to secure participation by members 
of the four communities listed in the press release (Reardon, 2017: 
70–93).
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For another thing, the kind of genetic variation that the HapMap 
project sought to document differed in important ways from anything 
that had gone before. By the time that planning for the HapMap Project 
got under way, research using increasingly detailed SNP maps was 
revealing new details about how the human genome is structured. 
Among other things, it showed that DNA is organized not just into 
chromosomes but, at a finer level of organization, into haplotypes (Daly 
et al., 2001; Gabriel et al., 2002). A haplotype is a specific combination 
of SNPs that are not only situated close together on the genome but 
also tend to be inherited together across many generations – they 
exhibit particularly close genetic linkage, in other words. For molecular 
geneticists interested in mapping SNPs, and ultimately in identifying 
genetic variants associated with common diseases, the existence of hap-
lotypes provided a welcome methodological shortcut: if researchers 
identified the presence of one or more SNPs peculiar to a particular 
haplotype, then they could infer with a high degree of probability what 
other SNPs markers were likely to be located in the immediate vicinity. 
Consequently, the HapMap project was organized with the express 
purpose of collecting not just SNPs but haplotypes as the preferred 
markers of human genetic variation.
However, the turn to haplotypes also opened the door to other kinds 
of genetic analysis. Since haplotypes are groups of genetic markers that 
tend to be inherited together, geneticists were able to read them not just 
as units of genetic variation but as indicators of common descent: if 
individuals share a haplotype, they must also have a common ancestor. 
In the context of the sampling strategy adopted by the HapMap Project 
this aspect of haplotypes quickly acquired a set of meanings that went 
well beyond the Project’s professed claim to be concerned solely with 
variation. HapMap researchers did not just collect DNA samples from 
individuals; they sampled what they saw as specific populations, defined 
by ethnic identity and geographical location. As a result, the particular 
patterns of haplotypes identified in each of those populations were 
strongly associated from the start with particular ethnic groups and 
their supposedly disparate ancestral origins. As a number of commenta-
tors have observed, the particular choice of populations to study, in 
Africa, Asia and white North America, effectively served to reinscribe 
long-standing ideas about race into the findings of the HapMap Project, 
including the idea that different racial types could be mapped onto 
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particular continental locations (e.g. Duster, 2015; Hamilton, 2008). 
More generally, the very act of assembling different groups of people to 
sample, then characterising the differences between those groups in 
terms of distinctive hereditary patterns of haplotypes, served in effect 
to constitute the very populations which those haplotypes were sup-
posed to represent (Reardon, 2017: 80–82).
This concern with sampling disparate populations, and the idea that 
those populations were genetically different from one another in impor-
tant ways, in turn resonated with another, rather different understand-
ing of populations that was becoming increasingly salient in debates 
about the feasibility of association studies as a means of identifying 
disease genes. As we have seen, earlier family linkage methods for iden-
tifying disease genes had not involved any explicit conceptualization of 
populations, since such studies focused on families as the object and 
means of investigation. However, once geneticists began considering 
the possibility of conducting association studies, the language of ‘popu-
lations’, and particular technical ideas about those populations, became 
central to their work.
For at least three decades before medical geneticists began to con-
sider adopting association methods to elucidate genetic factors in 
disease, epidemiologists had been refining those methods for use in 
identifying environmental and other causes of ill health. Central to their 
methodological armamentarium were so-called case-control studies. In 
order to identify possible causes of illness, epidemiological researchers 
typically compare a group of affected cases with a group of non-affected 
controls and seek to identify statistical associations between the occur-
rence of the disease and specific environmental or other factors. In 
the course of developing such methods epidemiologists quickly real-
ized that false positive results can occur if the cases and controls are 
not sufficiently similar to one another in relevant respects. Systematic 
differences between cases and controls, for instance in potentially con-
founding factors such as age or socio-economic status, could lead to 
misleading statistical associations between disease and environmental 
or other circumstances. For this reason, as early as the 1950s epide-
miologists developed tools and methodologies designed to ensure as 
far as possible that cases and controls embodied the same ‘population 
structure’.
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In such studies epidemiologists use the language of populations prag-
matically, to refer simply to the groups of cases and controls involved 
in the study. ‘Population’ in this sense implies nothing about the back-
ground of those who take part in a study, while ‘population structure’ is a 
consequence of the way that cases and controls are selected. That usage, 
and its connotations, changed markedly as medical geneticists began to 
adopt case-control methods, and epidemiological ideas about popula-
tions ran up against ideas drawn from population genetics. Problems of 
confounding due to unrecognized differences between cases and con-
trols quickly became apparent as attempts to find associations between 
disease and specific genetic markers began to gain momentum. For 
instance, a 1980s study conducted among the Pima people of Arizona 
initially appeared to show an association between type 2 diabetes and 
a particular genetic marker. However, on further analysis the associa-
tion was instead judged to be ‘an artifact of population admixture’. Pima 
people had been selected for study because they experience a much 
higher incidence of diabetes than white North Americans – a fact that 
researchers hoped would facilitate their search for predisposing genes. 
However, on re-examining their findings the researchers found that the 
non-affected controls recruited into the study reported having more 
white Americans among their forebears than did the affected cases, 
who mostly claimed to have solely Pima ancestors. The researchers 
concluded that ‘the association was apparently because tribe members 
have different degrees of Caucasian ancestry’; they had been misled 
by their failure to select ‘a control group that is perfectly matched for 
ethnic ancestry’ (Lander and Schork, 1994: 2041–2042).
It is worth pausing to reflect on the language adopted here. It reveals 
an important slippage: from thinking about populations and popula-
tion structure in the instrumental language of epidemiology – referring 
simply to those individuals who together make up a study population 
– to thinking about populations in terms of population genetics – refer-
ring to the larger groups of people from which those individuals are 
judged to have been drawn. It also reveals a tendency for geneticists 
to think about ‘population structure’ not simply as an artefact of the 
selection of cases and controls but as something that already exists in 
the world from which the cases and controls are selected. This is par-
ticularly clear in the way that ‘population structure’ was equated with 
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‘population admixture’ in the Pima diabetes study. The very notion of 
‘population admixture’ presumed not only that the Pima people from 
whom the research participants were drawn represented an uneven mix 
of two previously distinct genetic populations – the original Pima and 
‘Caucasians’ – but also that the cases and controls had in effect been 
drawn from different sub-populations with ‘different degrees of Cauca-
sian ancestry’. In genetic case-control studies, in other words, the ‘pop-
ulations’ which non-genetic epidemiologists would in principle have 
understood to have been constituted through the act of selecting cases 
and controls now came, in practice, to be seen as representing genetic 
populations that existed independently of the study methodology.
Such thinking persisted as high-density SNP maps and, subsequently, 
haplotype maps became available and researchers began conducting 
much more high-powered association studies using much larger popu-
lations of cases and controls. In such large-scale studies the potentially 
confounding effects of population structure (in the narrow epidemio-
logical sense) would present a constant risk of spurious association. 
Consequently, researchers began developing increasingly powerful sta-
tistical techniques for analysing the distribution of SNPs within study 
populations, in order to discern any systematic differences between 
cases and controls. Their arguments were marked by constant slippage 
between instrumental talk of study populations and realist talk of popu-
lations of origin, and between population structure and population 
admixture (e.g. Devlin and Roeder, 1999; Marchini, Cardon, Phillips 
and Donnelly, 2004; Pritchard and Donnelly, 2001). This slippage was 
reinforced by the rolling-out of the HapMap Project and the growing 
use of haplotypes to identify population structure in association studies 
of disease-linked genetic markers.
Since the early 2000s association studies have proliferated and 
expanded, attracting large-scale research funding to study genetic 
factors in an increasingly wide range of medical and other conditions. 
Analysis of haplotypes is now routinely used in such studies as a means 
of controlling for population structure and ensuring that cases and 
controls are properly matched. In principle, this need not involve 
making inferences about what external populations might be repre-
sented in a study. It is possible, for instance, to use haplotype analysis 
to ensure simply that cases are compared with haplotypically similar 
controls within the study population. In practice, however, haplotype 
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analysis commonly draws on assumptions about the ancestry of study 
participants, and about the genetic make-up of geographically and eth-
nically defined populations from around the globe. The method of 
admixture mapping, for instance, relies on researchers not only identi-
fying different genetic sub-populations within the study population but 
also attributing common ancestry and geographical origins to those 
sub-populations (Fujimura, Rajagopalan, Ossorio and Doksum, 2010; 
Fullwiley, 2008). By contrast, attributions of ancestry are not a neces-
sary step in large-scale genome-wide association studies, which use 
specialized software to conduct purely statistical analyses of population 
structure. Even here, however, the haplotypes used to conduct such 
analyses typically derive from initiatives such as the HapMap Project, 
and hence ultimately refer back to assumptions about the differences 
between geographically and ethnically defined populations; while 
researchers often make their own assumptions about what ancestral 
populations they might expect to be represented in their study sample 
when deciding how to interpret and classify the sub-populations identi-
fied by their software. As a result, ideas of race, ethnicity and the genetic 
differences between populations are constantly being reinscribed in 
research into the genetic determinants of common disorders (Fujimura 
and Rajagopalan 2011; Gannett, 2014).
Conclusion
During the 1980s and 1990s efforts to identify and map genetic variants 
of possible significance for disease aetiology focused primarily on fami-
lies. More recently, such research has shifted to include large-scale asso-
ciation studies in populations rather than in families. This has in turn 
led to the development of new methods to determine and control for 
population structure, which, in the case of genomic research, has come 
to mean the presence of sub-populations of different biological ances-
try. Researchers are accordingly anxious to know about the genomic 
constitution not just of those populations that are the principle focus 
of their research but of other populations that might in effect intrude 
into their study samples. The implications of this have been twofold.
First, it has entailed a shift in medical thinking about human popula-
tions. Not only has it fostered a new reification of the idea of a popula-
tion as something that is defined by common biological descent; it has 
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also led to a renewed interest in finding molecular techniques for dif-
ferentiating between such populations. As Joan Fujimura and Ramya 
Rajagopalan put it, ‘contrary to emphasizing the notion that humans 
are all related’, studies of population structure in the context of genomic 
association studies are ‘buttressed by a logic of difference’ (Fujimura 
and Rajagopalan, 2011, 21). This logic of difference provides a vehicle 
by which old and supposedly discredited biological notions of race find 
their way back into human genetics.
Second, this new thinking about genetic populations, and the desire 
to differentiate between them, has led to the rolling-out of genetic sam-
pling on an increasingly global scale. In order to know what genes might 
be involved in the incidence of heart disease among the inhabitants of 
America or Britain, researchers now need to know about the genetic 
constitution of populations from Mexico to Kenya to Japan. Local 
studies must routinely take into account the global distribution of genes 
and genotypes. In this respect, research into the genetic causes of 
disease, wherever it is conducted, is increasingly global in its purview, 
even when it is local and parochial in its concerns. This has prompted 
a proliferation of studies, from the International HapMap Project to the 
Human Heredity and Health in Africa (H3Africa) Initiative (launched 
in 2010), designed to reveal in ever more detail the genetic make-up of 
populations around the world.
Advocates of such initiatives declare that they are expected to benefit 
the populations being studied. But, insofar as the data they produce are 
used in the search for disease-causing gene variants, the vast majority of 
that work has been oriented towards elucidating and ultimately reliev-
ing the health problems of people – especially white people – living 
in North America and Europe (Need and Goldstein, 2009; Popejoy 
and Fullerton, 2016). By comparison, the flow of medical knowledge, 
and of such health interventions as result from these studies, back to 
the world’s poorer regions has been tiny. For one thing, the extent to 
which knowledge about genetic causes of disease among Europeans 
and North Americans is applicable to people with different genetic 
constitutions is often unclear. For another, impoverished patients 
and health systems simply do not have the resources to enable them 
to make use of the often expensive and complex interventions that 
modern biomedicine affords. The outcome of human genetic variation 
research in Africa, Asia and South America has been overwhelmingly to 
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facilitate the development of health-related investigations and interven-
tions among white Europeans and Americans. To the extent that this 
is the case, the globalization of genomic research has tended simply to 
reproduce the extractive relationships of neo-colonialism by extracting 
biological resources from the global South and realizing the value of 
those resources predominantly in the global North.
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